• Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

    Источник: Nasdaq GlobeNewswire / 22 ноя 2023 09:00:00   America/New_York

    YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023, at 3:30 p.m. ET.

    To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

    A replay of the webcast will be available for 60 days following the conclusion of the event.

    About Optinose
    Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

    Optinose Investor Contact
    Jonathan Neely
    jonathan.neely@optinose.com
    267.521.0531


    Primary Logo

Опубликовать